Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
作者：
Wink, Krista [1 ]
Belderbos, Jose [2 ]
Dieleman, Edith [3 ]
Rossi, Maddalena [2 ]
Rasch, Coen [3 ]
Damhuis, Ronald [4 ]
Houben, Ruud [1 ]
Troost, Esther [5 ,6 ]
机构：
[1] Maastro Clin, Radiat Oncol, Maastricht, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[3] Amsterdam Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[4] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands
[5] Med Fac, Dept Radiat Oncol, Dresden, Germany
[6] Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; metformin; Radiotherapy; Diabetes;
D O I：
10.1016/j.jtho.2016.11.280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA09.06
引用
收藏
页码：S278 / S279
页数：2
相关论文
共 50 条
[31]   Use of chemo-radiotherapy in locally advanced non-small cell lung cancer [J].
Novello, S ;
Le Chevalier, T .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) :292-299
[32]   Emerging Role of Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer [J].
Mulherkar, Ria ;
Grewal, Amardeep S. ;
Berman, Abigail T. .
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (04) :212-217
[33]   Modified VMAT Plans for Locally Advanced Centrally Located Non-Small Cell Lung Cancer (NSCLC) [J].
Cheung, Eva Y. W. ;
Kwong, Virginia H. Y. ;
Chan, Fandy Y. C. ;
Cheng, Dominic Y. T. ;
Cheng, Janice K. Y. ;
Yung, Sapphire H. Y. ;
Chan, Kiris T. K. ;
Cheung, Kelly T. Y. ;
Cheung, Tracy S. W. ;
Yiu, Janna C. L. .
LIFE-BASEL, 2021, 11 (10)
[34]   Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis [J].
Yuan, Meng ;
Zhai, Yirui ;
Men, Yu ;
Wang, Jianyang ;
Deng, Lei ;
Wang, Wenqing ;
Bao, Yongxing ;
Yang, Xu ;
Sun, Shuang ;
Ma, Zeliang ;
Liu, Yunsong ;
Wang, Jun ;
Zhu, Hui ;
Hui, Zhouguang .
THORACIC CANCER, 2021, 12 (23) :3208-3215
[35]   A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC). Effective palliation and patients' convenience [J].
Plataniotis, GA ;
Kouvaris, JR ;
Dardoufas, C ;
Kouloulias, V ;
Theofanopoulou, MA ;
Vlahos, L .
LUNG CANCER, 2002, 35 (02) :203-207
[36]   EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer [J].
Xu, Yaping ;
Zhang, Yiping ;
Ma, Shenglin .
LUNG CANCER, 2011, 73 (03) :249-255
[37]   The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis [J].
Wang, Xinshuai ;
Ding, Xuezhen ;
Kong, Dejiu ;
Zhang, Li ;
Guo, Yibo ;
Ren, Jing ;
Hu, Xiaochen ;
Yang, Junqiang ;
Gao, Shegan .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) :229-236
[38]   Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer [J].
Sher, David J. ;
Gielda, Benjamin T. ;
Liptay, Michael J. ;
Warren, William H. ;
Batus, Marta ;
Fidler, Mary Jo ;
Garg, Shalini ;
Bonomi, Philip .
CLINICAL LUNG CANCER, 2013, 14 (04) :370-375
[39]   Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer [J].
Jiang, Nan ;
Chen, Xiao-Cen ;
Zhao, Yue .
SUPPORTIVE CARE IN CANCER, 2013, 21 (03) :785-791
[40]   Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer [J].
Kang, Byung-Hee ;
Li, Xue ;
Son, Jaeman ;
Song, Changhoon ;
Kang, Hyun-Cheol ;
Kim, Hak Jae ;
Wu, Hong-Gyun ;
Lee, Joo Ho .
FRONTIERS IN ONCOLOGY, 2022, 12
12345